Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q2
Sell
-54,200
Closed -$2.82M 3711
2018
Q1
$2.82M Hold
54,200
﹤0.01% 1799
2017
Q4
$3.31M Buy
54,200
+45,200
+502% +$2.88M ﹤0.01% 1776
2017
Q3
$496K Hold
9,000
﹤0.01% 2911
2017
Q2
$382K Buy
9,000
+1,000
+13% +$44.4K ﹤0.01% 2930
2017
Q1
$336K Buy
+8,000
New +$293K ﹤0.01% 2919
2014
Q2
Sell
-40,000
Closed -$677K 4218
2014
Q1
$677K Sell
40,000
-206,000
-84% -$3.84M ﹤0.01% 3353
2013
Q4
$4.7M Sell
246,000
-7,200
-3% -$117K 0.01% 1726
2013
Q3
$3.97M Buy
+253,200
New +$3.54M 0.01% 1810

Other funds holding CGNX

David Shaw's CGNX Position: Q2 2026 in Review

David Shaw increased its Cognex (CGNX) stake by 971% in Q2 2026, buying an estimated $5.59M and bringing the position to 101,700 shares worth $7.37M. The position accounts for ﹤0.01% of the portfolio, ranked #2094.

David Shaw first reported a position in CGNX in Q2 2013 and has held it in 38 quarters since. The position peaked at $56.1M in Q2 2021. 649 funds tracked by Wall St. Rank hold CGNX as of Q2 2026.

  • David Shaw held 101,700 shares of Cognex worth $7.37M as of Q2 2026.
  • David Shaw bought 92,205 Cognex shares in Q2 2026, an estimated $5.59M.
  • Cognex made up ﹤0.01% of David Shaw's portfolio in Q2 2026, its #2094 holding.
  • David Shaw first reported a position in Cognex in Q2 2013 and has held it in 38 quarters since.
  • David Shaw's Cognex position peaked at $56.1M in Q2 2021.
  • 649 funds tracked by Wall St. Rank held Cognex as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.